Noninvasive Prenatal Diagnostics Market
1 Study Coverage
1.1 Noninvasive Prenatal Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Noninvasive Prenatal Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Noninvasive Prenatal Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Noninvasive Prenatal Diagnostics Market Size for the Year 2017-2028
1.3 Noninvasive Prenatal Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Noninvasive Prenatal Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Noninvasive Prenatal Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Noninvasive Prenatal Diagnostics Market Dynamics
1.4.1 Noninvasive Prenatal Diagnostics Industry Trends
1.4.2 Noninvasive Prenatal Diagnostics Market Drivers
1.4.3 Noninvasive Prenatal Diagnostics Market Challenges
1.4.4 Noninvasive Prenatal Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Noninvasive Prenatal Diagnostics by Type
2.1 Noninvasive Prenatal Diagnostics Market Segment by Type
2.1.1 Services
2.1.2 Instrument
2.2 Global Noninvasive Prenatal Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Noninvasive Prenatal Diagnostics Market Size by Type (2017-2028)
2.4 United States Noninvasive Prenatal Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Noninvasive Prenatal Diagnostics Market Size by Type (2017-2028)
3 Noninvasive Prenatal Diagnostics by Application
3.1 Noninvasive Prenatal Diagnostics Market Segment by Application
3.1.1 Hospital
3.1.2 Personal
3.1.3 Other
3.2 Global Noninvasive Prenatal Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Noninvasive Prenatal Diagnostics Market Size by Application (2017-2028)
3.4 United States Noninvasive Prenatal Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Noninvasive Prenatal Diagnostics Market Size by Application (2017-2028)
4 Global Noninvasive Prenatal Diagnostics Competitor Landscape by Company
4.1 Global Noninvasive Prenatal Diagnostics Market Size by Company
4.1.1 Top Global Noninvasive Prenatal Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Noninvasive Prenatal Diagnostics Revenue by Player (2017-2022)
4.2 Global Noninvasive Prenatal Diagnostics Concentration Ratio (CR)
4.2.1 Noninvasive Prenatal Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Noninvasive Prenatal Diagnostics in 2021
4.2.3 Global Noninvasive Prenatal Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Noninvasive Prenatal Diagnostics Headquarters, Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Noninvasive Prenatal Diagnostics Headquarters and Area Served
4.3.2 Global Noninvasive Prenatal Diagnostics Companies Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Noninvasive Prenatal Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Noninvasive Prenatal Diagnostics Market Size by Company
4.5.1 Top Noninvasive Prenatal Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Noninvasive Prenatal Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Noninvasive Prenatal Diagnostics Market Size by Region
5.1 Global Noninvasive Prenatal Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Noninvasive Prenatal Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Noninvasive Prenatal Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Noninvasive Prenatal Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Noninvasive Prenatal Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Noninvasive Prenatal Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Natera
7.1.1 Natera Company Details
7.1.2 Natera Business Overview
7.1.3 Natera Noninvasive Prenatal Diagnostics Introduction
7.1.4 Natera Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.1.5 Natera Recent Development
7.2 Illumina
7.2.1 Illumina Company Details
7.2.2 Illumina Business Overview
7.2.3 Illumina Noninvasive Prenatal Diagnostics Introduction
7.2.4 Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.2.5 Illumina Recent Development
7.3 BGI Diagnosis
7.3.1 BGI Diagnosis Company Details
7.3.2 BGI Diagnosis Business Overview
7.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Introduction
7.3.4 BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.3.5 BGI Diagnosis Recent Development
7.4 Ariosa Diagnostics
7.4.1 Ariosa Diagnostics Company Details
7.4.2 Ariosa Diagnostics Business Overview
7.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Introduction
7.4.4 Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.4.5 Ariosa Diagnostics Recent Development
7.5 Quest Diagnostics
7.5.1 Quest Diagnostics Company Details
7.5.2 Quest Diagnostics Business Overview
7.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
7.5.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.5.5 Quest Diagnostics Recent Development
7.6 Premaitha Health
7.6.1 Premaitha Health Company Details
7.6.2 Premaitha Health Business Overview
7.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Introduction
7.6.4 Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.6.5 Premaitha Health Recent Development
7.7 NIPD Genetics
7.7.1 NIPD Genetics Company Details
7.7.2 NIPD Genetics Business Overview
7.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Introduction
7.7.4 NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.7.5 NIPD Genetics Recent Development
7.8 Labcorp
7.8.1 Labcorp Company Details
7.8.2 Labcorp Business Overview
7.8.3 Labcorp Noninvasive Prenatal Diagnostics Introduction
7.8.4 Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.8.5 Labcorp Recent Development
7.9 Ravgen
7.9.1 Ravgen Company Details
7.9.2 Ravgen Business Overview
7.9.3 Ravgen Noninvasive Prenatal Diagnostics Introduction
7.9.4 Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.9.5 Ravgen Recent Development
7.10 LifeCodexx
7.10.1 LifeCodexx Company Details
7.10.2 LifeCodexx Business Overview
7.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Introduction
7.10.4 LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.10.5 LifeCodexx Recent Development
7.11 TrovaGene
7.11.1 TrovaGene Company Details
7.11.2 TrovaGene Business Overview
7.11.3 TrovaGene Noninvasive Prenatal Diagnostics Introduction
7.11.4 TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.11.5 TrovaGene Recent Development
7.12 Quest Diagnostics
7.12.1 Quest Diagnostics Company Details
7.12.2 Quest Diagnostics Business Overview
7.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
7.12.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.12.5 Quest Diagnostics Recent Development
7.13 Berry Genomics
7.13.1 Berry Genomics Company Details
7.13.2 Berry Genomics Business Overview
7.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Introduction
7.13.4 Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
7.13.5 Berry Genomics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Noninvasive Prenatal Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Noninvasive Prenatal Diagnostics Market Trends
Table 3. Noninvasive Prenatal Diagnostics Market Drivers
Table 4. Noninvasive Prenatal Diagnostics Market Challenges
Table 5. Noninvasive Prenatal Diagnostics Market Restraints
Table 6. Global Noninvasive Prenatal Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Noninvasive Prenatal Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Noninvasive Prenatal Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Noninvasive Prenatal Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Noninvasive Prenatal Diagnostics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Noninvasive Prenatal Diagnostics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Noninvasive Prenatal Diagnostics Revenue Share by Player, 2017-2022
Table 13. Global Noninvasive Prenatal Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Noninvasive Prenatal Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Prenatal Diagnostics as of 2021)
Table 15. Top Players of Noninvasive Prenatal Diagnostics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Noninvasive Prenatal Diagnostics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Noninvasive Prenatal Diagnostics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Noninvasive Prenatal Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Noninvasive Prenatal Diagnostics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Noninvasive Prenatal Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Noninvasive Prenatal Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Noninvasive Prenatal Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Noninvasive Prenatal Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Noninvasive Prenatal Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Noninvasive Prenatal Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Noninvasive Prenatal Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Noninvasive Prenatal Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Natera Company Details
Table 31. Natera Business Overview
Table 32. Natera Noninvasive Prenatal Diagnostics Product
Table 33. Natera Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 34. Natera Recent Development
Table 35. Illumina Company Details
Table 36. Illumina Business Overview
Table 37. Illumina Noninvasive Prenatal Diagnostics Product
Table 38. Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 39. Illumina Recent Development
Table 40. BGI Diagnosis Company Details
Table 41. BGI Diagnosis Business Overview
Table 42. BGI Diagnosis Noninvasive Prenatal Diagnostics Product
Table 43. BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 44. BGI Diagnosis Recent Development
Table 45. Ariosa Diagnostics Company Details
Table 46. Ariosa Diagnostics Business Overview
Table 47. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product
Table 48. Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 49. Ariosa Diagnostics Recent Development
Table 50. Quest Diagnostics Company Details
Table 51. Quest Diagnostics Business Overview
Table 52. Quest Diagnostics Noninvasive Prenatal Diagnostics Product
Table 53. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 54. Quest Diagnostics Recent Development
Table 55. Premaitha Health Company Details
Table 56. Premaitha Health Business Overview
Table 57. Premaitha Health Noninvasive Prenatal Diagnostics Product
Table 58. Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 59. Premaitha Health Recent Development
Table 60. NIPD Genetics Company Details
Table 61. NIPD Genetics Business Overview
Table 62. NIPD Genetics Noninvasive Prenatal Diagnostics Product
Table 63. NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 64. NIPD Genetics Recent Development
Table 65. Labcorp Company Details
Table 66. Labcorp Business Overview
Table 67. Labcorp Noninvasive Prenatal Diagnostics Product
Table 68. Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 69. Labcorp Recent Development
Table 70. Ravgen Company Details
Table 71. Ravgen Business Overview
Table 72. Ravgen Noninvasive Prenatal Diagnostics Product
Table 73. Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 74. Ravgen Recent Development
Table 75. LifeCodexx Company Details
Table 76. LifeCodexx Business Overview
Table 77. LifeCodexx Noninvasive Prenatal Diagnostics Product
Table 78. LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 79. LifeCodexx Recent Development
Table 80. TrovaGene Company Details
Table 81. TrovaGene Business Overview
Table 82. TrovaGene Noninvasive Prenatal Diagnostics Product
Table 83. TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 84. TrovaGene Recent Development
Table 85. Quest Diagnostics Company Details
Table 86. Quest Diagnostics Business Overview
Table 87. Quest Diagnostics Noninvasive Prenatal Diagnostics Product
Table 88. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 89. Quest Diagnostics Recent Development
Table 90. Berry Genomics Company Details
Table 91. Berry Genomics Business Overview
Table 92. Berry Genomics Noninvasive Prenatal Diagnostics Product
Table 93. Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 94. Berry Genomics Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Noninvasive Prenatal Diagnostics Product Picture
Figure 2. Global Noninvasive Prenatal Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Noninvasive Prenatal Diagnostics Market Size 2017-2028 (US$ Million)
Figure 4. United States Noninvasive Prenatal Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Noninvasive Prenatal Diagnostics Market Size 2017-2028 (US$ Million)
Figure 6. United States Noninvasive Prenatal Diagnostics Market Share in Global 2017-2028
Figure 7. Noninvasive Prenatal Diagnostics Report Years Considered
Figure 8. Product Picture of Services
Figure 9. Product Picture of Instrument
Figure 10. Global Noninvasive Prenatal Diagnostics Market Share by Type in 2022 & 2028
Figure 11. Global Noninvasive Prenatal Diagnostics Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Noninvasive Prenatal Diagnostics Market Share by Type (2017-2028)
Figure 13. United States Noninvasive Prenatal Diagnostics Market Share by Type in 2022 & 2028
Figure 14. United States Noninvasive Prenatal Diagnostics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Noninvasive Prenatal Diagnostics Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Personal
Figure 18. Product Picture of Other
Figure 19. Global Noninvasive Prenatal Diagnostics Market Share by Application in 2022 & 2028
Figure 20. Global Noninvasive Prenatal Diagnostics Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Noninvasive Prenatal Diagnostics Market Share by Application (2017-2028)
Figure 22. United States Noninvasive Prenatal Diagnostics Market Share by Application in 2022 & 2028
Figure 23. United States Noninvasive Prenatal Diagnostics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Noninvasive Prenatal Diagnostics Market Share by Application (2017-2028)
Figure 25. North America Noninvasive Prenatal Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Noninvasive Prenatal Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Latin America Noninvasive Prenatal Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 45. Mexico Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Brazil Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Argentina Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Turkey Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Saudi Arabia Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. UAE Noninvasive Prenatal Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Natera Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 53. Illumina Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 54. BGI Diagnosis Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 55. Ariosa Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 56. Quest Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 57. Premaitha Health Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 58. NIPD Genetics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 59. Labcorp Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 60. Ravgen Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 61. LifeCodexx Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 62. TrovaGene Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 63. Quest Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 64. Berry Genomics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Industry Market Size
